ASIP Partners with Elsevier to Publish The American
Journal of Pathology
Authors’ Frequently Asked Questions
Will the direction/scope of the AJP change?
direction of the AJP will continue to be molded by the Journal’s
Editors, publishing “high-quality, original papers on the cellular
and molecular biology of disease. The editors accept manuscripts that
advance basic and translational knowledge of the pathogenesis,
classification, diagnosis, and mechanisms of disease, without preference
for a specific analytic method. High priority is given to studies on
human disease and relevant experimental models using cellular,
molecular, animal, biological, chemical, and immunological approaches in
conjunction with morphology.”
How should I submit my manuscripts?
Authors should continue to submit new and revised manuscripts online at
Rapid Review (https://www.rapidreview.com/ASIP2/CALogon.jsp).
In an unrelated move, the online submission interface was updated in
November to improve the author experience.
Will the editorial review process change?
editorial decision-making process will remain with the Editor-in-Chief
and Associate Editors. We will continue to seek expert review from
experienced external reviewers to aid this process.
Will author costs of publishing in the AJP
Author costs of publishing will remain the same ($95/page, $550/color
figure, $50/black and white figure, $50/table, $95/supplemental file).
As always, any future changes in publication costs will be announced in
advance and will appear in revised Instructions to Authors.
How will I review proofs of my accepted article? Proofs will be provided by Elsevier
via Cadmus Communications (Cenveo) via email for download, as in the
past. You should follow the instructions therein for where to return
your corrected pages.
How will my article be published?
will remain online and in print form, at the same high
quality you have come to expect.
Will the AJP continue to be compliant with PubMed
deposit requirements? The AJP will continue to deposit
final published articles funded by NIH, HHMI, Wellcome Trust, and MRC in
PubMed Central in compliance with each funding agency’s requirements.